Anthony Japour

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Anthony Japour

Earlier roles on record: Board Member at Cocrystal Pharma, Inc. (COCP) until March 10, 2026. Cocrystal Pharma, Inc. reported in an 8-K filed March 13, 2026 that Anthony Japour was terminated as member of the Company's board of directors, effective March 10, 2026.

“Cocrystal Pharma, Inc. (the “Company”) sadly learned on March 10, 2026 that Dr. Anthony Japour, a member of the Company’s board of directors, passed away.”

Cocrystal Pharma, Inc. Form 8-K, filed March 13, 2026 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Research with Equibles

Turn this profile into a cited research brief

Start with a question tailored to the filings and events on this page, or connect Equibles financial data to ChatGPT or Claude.

Suggested question: “Summarize Anthony Japour's recent executive appointments or departures and cite the source filings.”

Use in your AI

Affiliation history

Recorded current and former roles; source labels appear when available.

Cocrystal Pharma, Inc. (COCP)
Board Member

Proxy statement

Start not stated–2026-03-10

Company network

Recorded roles and call appearances connecting this person to public companies.

Cocrystal Pharma, Inc.

COCP

Board Member

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.

Executive change Terminated: member of the Company's board of directors Cocrystal Pharma, Inc. (COCP)
2026-03-10